Abstract:
This invention relates to a novel use of coenzyme Q10 in animal husbandry, as additive or supplement to animal feed/fodder and animal beverages, and to the enrichment of animal tissues, especially meat with coenzyme Q10. A further object of this invention is animal tissue enriched with coenzyme Q10. Animal tissues within the scope of this invention are in addition to all types of meat, bones, skins and the like, poultry eggs and the milk of dairy animals as well. The invention comprises a use of coenzyme Q10 to improve the effectiveness of animal husbandry, and the production of animal tissues with an increased content of said enzyme, wherein the intake of coenzyme Q10 by the animals is performed by consumption or direct administration into or onto the body, wherein coenzyme Q10 is in a convenient water-soluble or water-insoluble form, preferably in the form of enhanced bioavailability, and the animals consume the coenzyme Q10 or receive it in another manner during all their lifetime or at a determined period any time during their lifetime, preferably during their growth phase and/or at an optional period prior to slaughter, more preferably during growth phases and/or 3-90 days prior to slaughter, and that the animals consume 1-1000 mg of coenzyme Q10 per kg of body weight daily, preferably 1-50 mg, more preferably 1-20 mg. Coenzyme Q10 is added to animal feed/fodder or beverage. The feed/fodder is any nutrient for animals, unprocessed or processed, natural or artificial and industrially manufactured, respectively.
Abstract:
The invention presents the applications of compounds, which contain a combination of a hydrophobic group with a group, which is reactive with the cysteine residue for the binding to protein MD-2. The compounds are covalently linked to MD-2, which is either free or in the complex with other molecules. The said compounds replace or prevent binding of other ligands, especially bacterial endotoxin (lipopolysaccharide-LPS), which can otherwise lead towards unwanted activation of the immune response and acute or chronic inflammatory diseases.
Abstract:
The invention deals with the shorter fragment of 6-phosphofructo-l-kinase (PFK1) with molecular mass between 49 and 55 kDa that is not significantly inhibited by citric acid and/or its salts and is post-translationally modified. The 49-52 kDa fragment that is formed by post-translational modifications of the fungal enzyme retains positive regulatory properties and is activated by specific activators, yet is no more sensitive to inhibition by citric acid a substance that in higher organisms acts as a feed back inhibitor. The invention describes a procedure that includes the introduction of the gene coding for a shorter fragment into the eukaryotic cells with an aim to increase the metabolic flow through the glycolysis and concomitantly to increase the rate of primary and secondary metabolites synthesis. The invention describes the use of the shorter fragment in biotechnological procedures for production of primary and secondary metabolites.
Abstract:
The invention provides a method for enhanced genome engineering using CRISPR/Cas system tethered to exonucleases via different systems. By connecting Cas9 and exonucleases via heterodimeric peptides that form coiled-coils or via heterodimerization systems, greater indel mutations at desired genomic region occurs, resulting in higher genome editing rate. This novel improved CRISPR/Cas system can be exploited in different cell origins and organisms in various fields, where genome engineering is required and desired.
Abstract:
The present invention provides an anode interfacial protective layer, made from silylated cellulose optionally including ion conductive additive(s) and methods for their fabrication. The protective layer is capable of protecting common anode materials like lithium and lithium alloys from destructive reactions with other battery components, and in that way, enhance performance of a battery cell in which the protective layer is incorporated.
Abstract:
A process is described for removing ashes from biomasses, through a system (1) comprising mixing means (10) and (20), filtering means (30) and distilling means (40) and at least one storage system (50) to allow separating and removing ashes from biomasses, comprising the following steps: depolymerizing organic material present in the biomass and separating the organic material, depolymerized and dissolved in the solvent, with respect to a solid ash-rich residue; filtering the organic material, depolymerized and dissolved in the solvent; distilling and regenerating the solvent present in an environment with high temperature; and extracting and storing biomass without ashes. A system (1) for removing ashes from biomasses is further described.
Abstract:
The invention applies to the field of generating energy products and chemicals with high added value from renewable and alternative sources and examines the conversion of gas mixtures of methane and carbon dioxide into syngas. In particular there are provided a carrier material for carrying active metal phases, a solid catalyst, and processes for forming them. A carrier material of the invention comprises a homogenous solid solution of Ce x Zr 1 - x O 2-y having a face-centred cubic unit cell crystalline structure; wherein x is greater than 0 and less than 1 and y is from 0 to 1; and wherein x is not 0.5.
Abstract:
Method for the production of nanocrystalline cellulose from a cellulose-containing starting material, said method comprising contacting said starting material with a first solvent mixture comprising at least one first organic solvent and an acid, catalyst, for a period of time sufficient to dissolve components of said starting material other than nanocrystalline cellulose in said solvent mixture, thereby obtaining nanocrystalline cellulose dispersed in a dissolution mixture; adding a second solvent mixture to said nanocrystalline cellulose dispersed in a dissolution mixture, said second solvent mixture comprising at least one second organic solvent and less than 10% (wt.) water, thereby obtaining nanocrystalline cellulose in a diluted dissolution mixture; separating said nanocrystalline cellulose from said diluted dissolution mixture by at least one filtration or centrifugation step.
Abstract:
The invention of the preparation of zeolite ZSM-5 granulates free from inorganic binder provides a synthetic process for the preparation of highly crystalline zeolite granulates without using inorganic binder from amorphous sodium aluminosilicate granules. This invention falls within the scope of the inorganic chemical technology. Granules were prepared from the powdered dried amorphous sodium aluminosilicate gel without containing organic structure directing agent. The proposed synthesis process provides the preparation of the amorphous sodium aluminosilicate gel from sodium water-glass, sodium aluminate using less than 5% of zeolite ZSM-5 seed crystals. The pH value of the gel is adjusted using dilute sulfuric (VI) acid. Dried amorphous sodium aluminosilicate gel is granulated using sodium water-glass. Thermally treated amorphous sodium aluminosilicate granulate is transformed in the alkaline solution into crystalline zeolite ZSM-5 granulate by the hydrothermal synthesis from 22 to 28 hours at a temperature from 170 to 190°C.
Abstract:
The invention deals with mutated truncated mX- pfk A gene encoding shorter fragment of 6- phosphofructo-1 -kinase (PFKl), with no need for phosphorylation of the protein molecule for activation, that is not significantly inhibited by citric acid and/or its salts and ATP molecules. Active 49 -52 kDa fragment encoded by mt- pflt k gene, retains positive regulatory properties of the native protein and is activated in the presence of specific activators, while citric acid and ATP, important metabolites that function as feed back inhibitors in higher organisms do not reduce its activity. The invention deals with the use of modified shorter fragment in biotechnological processes for fabricating primary and secondary metabolites.